Challenge Accepted: Seat at the Table Report Shows Women Sustaining Momentum in Corporate Leadership

Maintaining gains amid DEI rollbacks and economic uncertainty demands bold leadership and accountability Executive Women of New Jersey (EWNJ) unveiled its biennial Seat at the Table Report today during its Corporate Gender Diversity Awards and Power Networking Breakfast at Brooklake Country Club. The report, the only one of its kind in New Jersey, provided a […]

POP MART MAKES ITS DEBUT AT THE ICONIC MACY’S THANKSGIVING DAY PARADE®, BRINGING “POP CITY” TO LIFE IN A CELEBRATION OF FRIENDSHIP, JOY, AND POP CULTURE

Beloved characters LABUBU, MOKOKO, and friends take center stage in a larger-than-life float during the event's 99th march, marking 15 years of creativity and global fandom Everyone's favorite characters are coming to New York City this Thanksgiving on November 27, 2025.POP MART, the global entertainment IP company at the intersection of art, fashion, and pop

One Stop Systems to Report Third Quarter 2025 Financial Results

One Stop Systems to Report Third Quarter 2025 Financial Results Conference Call to be Held Wednesday, November 5, 2025, at 10:00 a.m. ET GlobeNewswire October 22, 2025 ESCONDIDO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence

Alexandria Real Estate Equities, Inc./Alexandria Venture Investments Receives 2025 Charles A. Sanders, MD, Partnership Award From the Foundation for the National Institutes of Health

This prestigious award recognizes Alexandria's leadership in initiating and catalyzing a groundbreaking public-private partnership with the FNIH that leverages precision medicine to unravel the complexities of depression and drive a paradigm shift in treatment Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured, and pioneering owner, operator, and developer of collaborative Megacampus™ ecosystems

The Evolution of Precision Medicine in Age-Related Neurological Diseases, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how precision medicine strategies focusing on biomarkers, sub-classification and targeted therapeutics are advancing treatment of age-related neurological diseases. The featured speakers will share how patient-centric trial design and population-adjusted approaches ensure that research translates into real-world impact for older adults. Attendees will gain a scientific and operational perspective on how

Overcoming Late-Stage Formulations & Manufacturing Challenges with KinetiSol Technology, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how KinetiSol can boost bioavailability, streamline manufacturing and improve scalability for late-stage drug development. Attendees will gain insight into why spray drying is often chosen for early clinical development despite late-stage limitations. The featured speaker will discuss how converting spray-dried dispersions (SDDs) to KinetiSol™ dispersions (KSDs) improves bioavailability, pill burden

OncoHost Receives New York State Laboratory Permit, Expanding Availability of PROphetNSCLC® Precision Oncology Test

OncoHost, a technology company transforming the approach to precision medicine through plasma proteomics and AI, today announced that it has received a laboratory permit from the New York State Department of Health Wadsworth Center. This permit enables the company to offer its PROphetNSCLC® test to physicians and patients across New York State, marking a key

Spinogenix to Present Complete Phase 2a Clinical Trial Results for SPG601, a First-in-Class Fragile X Syndrome Treatment, at AACAP Conference

SPG601, Granted Fast Track Designation by the FDA, Reduced Signature Changes in High-Frequency Gamma Band Activity in Fragile X Syndrome Patients, a Common Inherited Form of Intellectual Disability and Autism, and Improved Measures of Cognitive Impairment Dr. Craig Erickson, Spinogenix Chief Medical Advisor, to Receive Prestigious for Contributions in Developmental Disabilities Spinogenix, Inc., a clinical-stage

VisionWave’s Counter-UAS Systems Featured by a U.S. Tier-1 Defense Partner at Association of the United States Army – AUSA 2025

Showcasing joint innovation and deepening collaboration at one of North America's largest defense exhibitions VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”) today announced that its Counter-Unmanned Aerial System (C-UAS) technologies were featured and installed on a Tier-1 U.S. defense contractor's platform during the Association of the United States Army (AUSA) Annual Meeting and

Gold Breaks $4,000 as Capital Shifts Toward Cash-Generating Producers

NetworkNewsWire Editorial Coverage A significant market rotation is underway. After years of heavy investment in inflated growth sectors such as technology and artificial intelligence, investors are increasingly steering capital toward tangible assets, particularly precious metals producers and near-term developers. What sets this cycle apart is that both gold and silver are climbing to record highs

Scroll to Top